The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells

被引:0
作者
D Saulep-Easton
F B Vincent
P S Quah
A Wei
S B Ting
C M Croce
C Tam
F Mackay
机构
[1] Monash University Central Clinical School,Department of Immunology
[2] Alfred Medical Research and Education Precinct (AMREP),Department of Haematology
[3] The Alfred Hospital,Division of Blood Cancers, Department of Medicine
[4] Australian Centre for Blood Diseases,Department of Molecular Virology
[5] Monash University Central Clinical School,Department of Haematology
[6] Alfred Medical Research and Education Precinct (AMREP),undefined
[7] Immunology and Medical Genetics,undefined
[8] The Ohio State University,undefined
[9] Peter MacCallum Cancer Centre,undefined
[10] St. Andrews’s Place,undefined
来源
Leukemia | 2016年 / 30卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Interleukin (IL)-10-producing B cells (B10 cells) have emerged as important regulatory elements with immunosuppressive roles. Chronic lymphocytic leukemia (CLL) B cells also secrete IL-10 and share features of B10 cells, suggesting a possible contribution of CLL B cells to immunosuppression in CLL patients. Factors controlling the emergence of B10 cells are not known. B-cell-activating factor of the tumor necrosis factor (TNF) family (BAFF) is critical for B-cell maturation and survival, and is implicated in the development and progression of CLL. We sought to investigate the role of BAFF in the emergence of IL-10-producing regulatory B cells in healthy donors and CLL patients. Here, we report that BAFF signaling promotes IL-10 production by CLL B cells in a mouse model of CLL and in CLL patients. Moreover, BAFF-mediated IL-10 production by normal and CLL B cells is mediated via its receptor transmembrane activator and cyclophilin ligand interactor. Our work uncovered a major targetable pathway important for the generation of regulatory B cells that is detrimental to immunity in CLL.
引用
收藏
页码:163 / 172
页数:9
相关论文
共 308 条
[91]  
Mauri C(undefined)undefined undefined undefined undefined-undefined
[92]  
Bosma A(undefined)undefined undefined undefined undefined-undefined
[93]  
Balkwill F(undefined)undefined undefined undefined undefined-undefined
[94]  
Montfort A(undefined)undefined undefined undefined undefined-undefined
[95]  
Capasso M(undefined)undefined undefined undefined undefined-undefined
[96]  
DiLillo DJ(undefined)undefined undefined undefined undefined-undefined
[97]  
Weinberg JB(undefined)undefined undefined undefined undefined-undefined
[98]  
Yoshizaki A(undefined)undefined undefined undefined undefined-undefined
[99]  
Horikawa M(undefined)undefined undefined undefined undefined-undefined
[100]  
Bryant JM(undefined)undefined undefined undefined undefined-undefined